myphysician360 Appoints Dr. Akash Parekh as Chief Medical Officer

Dr. Akash Parekh, Chief Medical Officer, myphysician360 ● Photo Credit: myphysician360

ATLANTA, September 11, 2024 (VSNewsNetwork.com) – myphysician360, a virtual healthcare provider, has named Dr. Akash Parekh as its new Chief Medical Officer. Dr. Parekh, an Internal Medicine Physician and Radiation Oncologist, brings expertise in healthcare innovation, regulatory experience, and a focus on underserved communities to his new role.

Dr. Parekh’s responsibilities will include overseeing the company’s clinical strategy, which is centered around its telemedicine program. This program partners with community pharmacies across the United States to increase healthcare access in rural and underserved regions. According to the company, this model leverages the relationships between local pharmacists and patients to deliver primary and urgent care through telemedicine.

"Dr. Parekh's exceptional background and expertise in both clinical care and health technology make him the perfect fit to lead myphysician360's medical strategy as we expand our services to meet the growing demand for accessible healthcare in rural and underserved areas," said Michael Muchnicki, CEO of myphysician360.

Dr. Parekh, who has published over two dozen papers and served as a senior advisor to health tech companies, previously worked as a Medical Officer in the FDA’s Center for Drug Evaluation and Research (CDER). "I’m excited to join myphysician360 as they work to reshape pharmacy and healthcare services, particularly in underserved regions," said Parekh.

myphysician360’s telemedicine platform is designed to provide year-round access to primary and urgent care services for patients in healthcare-scarce areas, utilizing a network of community pharmacies across the country.

For more information, visit myphysician360.com.

Source: myphysician360 via Newswire

Previous
Previous

Airiam Appoints Mike Gately as Senior Vice President of Revenue

Next
Next

Spare Raises $42 Million in Series B Funding to Expand Demand Response Transit Solutions